Navigation Links
Spectros Corporation Signs Distribution Agreements in Middle East
Date:12/6/2011

PORTOLA VALLEY, Calif., Dec. 6, 2011 /PRNewswire/ -- Spectros Corporation announced today an expansion of its distribution channels in the Middle East with the signing of distributors based in the UAE, with expansion to other areas of the Middle East under discussion. These groups will join other distributors already selling Spectros products outside of the U.S.

"We are excited by this continued expansion," noted Director of Sales Elizabeth van Thillo-Rohlff. "More and more physicians are recognizing the opportunity offered by the superior Spectros T-Stat® tissue oximeter, as was confirmed in recent independent studies."

Spectros T-Stat Oximeter is currently the only broadband tissue oximeter on the market in the U.S. and Europe. T-Stat competes in the marketplace with INVOS® oximeters marketed by Covidien, and FORE-SIGHT® oximeters marketed by CAS Medical. In reconstructive surgery, T-Stat competes with oximeters marketed by ViOptix.

An expanded array of probes, including broadband infrared Continuum® monitor, Ceres™ cerebral probes, and multi-site T-Stat monitors are currently in testing, pending FDA approval and release anticipated over the next year.

About Spectros

Spectros markets and licenses advanced molecular sensing and imaging devices that shed light on ischemia and cancer. The company's champion product, the T-Stat Tissue Oximeter, is the first medical device FDA-approved as sensitive to ischemia, an insufficient supply of oxygen to tissue.  T-Stat is the only commercially-available tissue oximeter that utilizes state-of-the-art broadband visible light spectroscopy (VLS). The non-invasive T-Stat system is used clinically to provide a continuous and real-time absolute value, utilizing 260 wavelengths, over the competing oximeter product lines that only use 2-4.

Spectros also develops molecular diagnostic tools for breast and prostate cancer, currently in phase I/II clinical trials supported by the National Cancer Institute.  Spectros is a venture-supported private concern and markets its products in the U.S. and internationally.

(Note:  Forward-looking statements are intended as a guide only, and do not constitute an offer for investment nor a guarantee of future events or returns.  Certain Spectros applications described above have not been reviewed and approved by the FDA, and are therefore labeled "for investigational use only." T-Stat, Continuum, and CereS are trademarks of the Spectros Corporation. INVOS is a trademark of Somanetics and Covidien. FORE-SIGHT is a trademark of CAS Medical).

For further information, visit www.spectros.com.


'/>"/>
SOURCE Spectros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Spectros Signs New International Distribution Deals
2. Spectros Signs New International Distribution Deals
3. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
4. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
5. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
6. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
7. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
8. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
9. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
10. M2SYS Biometric Software Solution Selected By GHG Corporation
11. Harris Corporation Adds Broadband Satellite Data Mode to JTRS-Approved Falcon III(R) AN/PRC-117G Multiband Manpack Radio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... , ... October 12, 2017 , ... ... with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of ... trends in analytical testing are being attributed to new regulatory requirements for all ...
(Date:10/11/2017)... Charlotte, N.C. (PRWEB) , ... October 11, 2017 ... ... ARCS® Foundation President Andi Purple announced Dr. Suneel I. Sheikh, the ... Laboratories ( ASTER Labs ), Inc. has been selected for membership in ...
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for any ... So which eye do you rinse first if a dangerous substance enters both eyes? It’s ... Wash with its unique dual eye piece. , “Whether its dirt and debris, or ...
(Date:10/11/2017)... ... 2017 , ... Proscia Inc ., a data solutions ... “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, Managing ... how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
Breaking Biology Technology: